Irisin Competitive ELISA Kit

Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes: E.A. Lawson, et al.; J. Clin. Endocrinol. Metab. 99, E881 (2014)

Implication of Circulating Irisin Levels with Brown Adipose Tissue and Sarcopenia in Humans: H.Y. Choi, et al.; J. Clin. Endocrinol. Metab. 99, 2778 (2014)

Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates: V. Singhal, et al.; PLoS One 9, e100218 (2014)

Circulating sclerostin and irisin are related and interact with gender to influence adiposity in adults with prediabetes: T. Klangjareonchai, et al.; Int. J. Endocrinol. 2014, ID261545 (2014)

Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients: M.J. Lee, et al.; Atheroscler. 242, 476 (2015)

Irisin levels in the progression of diabetes in sedentary women: I.D. Duran, et al.; Clin. Biochem. 48, 1268 (2015)

The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype: Y.C. Hwang, et al.; Cardiovasc. Diabetol. 15, 9 (2016)

Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization: J.E. Blevins, et al.; Am. J. Physiol. 310, R640 (2016)

Eicosapentaenoic acid regulates brown adipose tissue metabolism in high-fat-fed mice and in clonal brown adipocytes: M. Pahlavanni, et al.; J. Nutr. Bioche. 39, 101 (2017)